Compound W Liquid
Natural health product licensed in Canada
- Licence holder
- Medtech Products, Inc.
- NPN or DIN-HM
- 02230132
- Status
- Active licence
- Licence date
- 18 October 2007
- Revision date
- 18 November 2025
- Form
- Liquide
- Route of administration
- Topique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide salicylique | 17 % (p/p) |
Non-medicinal ingredients
Ethylcellulose, Poly(sorbate) 80, Camphre, Castor oil, Menthol, Acetone Collodian, Hypophosphorous Acid
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | 2 days |
Uses authorised in Canada
For the removal of common and plantar warts. For the removal of planter warts on the bottom of the feet. Wart remover.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Avoid applying on the surrounding skin - may sting or burn.
Source
Official Health Canada record, licence 02230132
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.